BE618035A - - Google Patents

Info

Publication number
BE618035A
BE618035A BE618035DA BE618035A BE 618035 A BE618035 A BE 618035A BE 618035D A BE618035D A BE 618035DA BE 618035 A BE618035 A BE 618035A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE618035A publication Critical patent/BE618035A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
BE618035D 1961-05-26 BE618035A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US112776A US3086911A (en) 1961-05-26 1961-05-26 Analgesic: 3, 4-dimethylbenzamide

Publications (1)

Publication Number Publication Date
BE618035A true BE618035A (fr)

Family

ID=22345779

Family Applications (1)

Application Number Title Priority Date Filing Date
BE618035D BE618035A (fr) 1961-05-26

Country Status (4)

Country Link
US (1) US3086911A (fr)
BE (1) BE618035A (fr)
FR (1) FR1815M (fr)
GB (1) GB926584A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
NL127996C (fr) * 1963-11-19
US3253991A (en) * 1963-11-22 1966-05-31 Burroughs Wellcome Co Prophylaxis against smallpox and treatment of vaccinia with 1-methylisatin beta-thiosemicarbazone
US3350396A (en) * 1964-06-09 1967-10-31 Horner Frank W Ltd Quaternary ammonium salts of morpholinoethyl 3, 4, 5-trimethoxybenzoate
NL128806C (fr) * 1965-10-12
US4601584A (en) * 1981-05-18 1986-07-22 Lowell E. Dewolf Wrist watch or clock rosary device

Also Published As

Publication number Publication date
US3086911A (en) 1963-04-23
GB926584A (en) 1963-05-22
FR1815M (fr) 1963-05-13

Similar Documents

Publication Publication Date Title
FR3124M (fr)
AT224007B (fr)
BE596839A (fr)
BE625968A (fr)
BE626727A (fr)
BE622823A (fr)
BE587184A (fr)
BE602240A (fr)
BE625741A (fr)
BE12203A (fr)
BE164003A (fr)
BE622492A (fr)
BE396226A (fr)
BE458606A (fr)
BE621793A (fr)
BE620883A (fr)
BE619352A (fr)
BE618525A (fr)
BE464928A (fr)
BE469342A (fr)
BE472265A (fr)
BE475425A (fr)
BE617496A (fr)
BE475477A (fr)
BE613828A (fr)